Heart Disease Trial, Recruiting NCT06101862 Sponsor: Rigshospitalet, Denmark Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06101862
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to hospital with a type of heart condition called a non-ST-elevation heart attack or unstable angina, and who have been recommended for a non-urgent heart artery imaging procedure.
  • People who have a blood test result showing elevated troponin (a marker of heart stress) or who have abnormal results on a heart tracing (ECG) suggesting reduced blood flow to the heart.
  • People who are able and willing to provide written consent to take part in the trial.

Who may not be able to join:

  • People whose condition is unstable and requires an urgent or emergency heart artery imaging procedure rather than a planned one.
  • People who have previously had a procedure to open blocked heart arteries (such as a stent) or heart bypass surgery.
  • People whose kidneys are not working well enough, based on a specific kidney function measurement falling below a certain level.
  • People whose heart attack is thought to have been caused by another condition rather than a blocked artery (referred to as a "type 2" heart attack).
  • People whose main diagnosis involves a serious problem with one of the heart valves, or who may need valve surgery.
  • People who have a history of a rare condition where a heart artery has spontaneously torn.
  • People where the quality of a particular heart scan (a CT scan of the heart arteries) is expected to be too poor to be useful.
  • People who have already had a heart artery CT scan or an invasive heart artery imaging procedure during the current hospital stay or within the past week.
  • People with a known allergy to a type of heart-rate medication called beta-blockers or to the dye used in imaging scans.
  • People who are pregnant or breastfeeding.
  • People who have already been enrolled in this trial before.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 38 68 38 68

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
1 October 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Number of participants with a combined endpoint of major adverse cardiac events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov